Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

0.71
Delayed Data
As of Dec 02
 -0.0131 / -1.81%
Today’s Change
0.26
Today|||52-Week Range
1.53
-46.62%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues78.7K1.1M6.3M13.2M
 
 
 
 
 
Cost of Goods Sold--332.8K1.6M1.7M
 
 
 
 
Depreciation And Amortization200.2K404.2K500.2K571.4K
 
 
 
 
 
 
Operating ExpensesGross Income--393.6K4.2M11.0M
 
 
 
 
General Expenses27.9M38.8M31.2M28.3M
 
 
 
 
 
Research And Development16.9M23.7M16.8M12.8M
 
 
 
 
 
Total Operating Expenses28.1M39.6M33.3M30.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-28.0M-38.4M-27.0M-17.3M
 
 
 
 
 
Extraordinary Credit32.1K0.00--0.00
 
 
Extraordinary Charge---1.5M-4.6M-4.4M
 
 
 
 
Pre-Tax Equity Earnings-----523.8K-305.3K
 
 
 
Interest Expense On Debt1.2M2.8M3.7M6.9M
 
 
 
 
 
Other Expenses-58.7K-16.9K72.7K26.8K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-29.2M-42.7M-35.7M-28.8M
 
 
 
 
 
Income Taxes0.000.000.00-436.1K
 
 
Minority Interest0.000.000.00-855.00
 
 
Preferred Dividend-43.3K0.000.00-46.0K
 
 
 
Discontinued Operations0.000.000.00758.6K
 
 
Net Income-29.2M-42.7M-35.7M-27.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS99.1M121.8M148.7M151.2M
 
 
 
 
 
Shares To Calculate EPS Diluted99.1M121.8M148.7M151.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.29-$0.35-$0.24-$0.18
 
 
 
 
 
EPS Diluted-$0.29-$0.35-$0.24-$0.18